New hope to prevent deadly bleeding in liver disease
NCT ID NCT06861075
Summary
This study is testing if a heart medication called carvedilol can safely lower high blood pressure in the liver's portal vein (portal hypertension) in people with cirrhosis. The goal is to see if this reduces the risk of dangerous digestive bleeding. Researchers will measure the pressure inside the liver using a special ultrasound scope before and after one month of treatment in 30 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Estaing Medecine Digestive Et Hepatobiliaire
RECRUITINGClermont-Ferrand, 63003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lise Laclautre
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
Contact
Conditions
Explore the condition pages connected to this study.